IT1243343B - Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva - Google Patents

Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva

Info

Publication number
IT1243343B
IT1243343B IT02094690A IT2094690A IT1243343B IT 1243343 B IT1243343 B IT 1243343B IT 02094690 A IT02094690 A IT 02094690A IT 2094690 A IT2094690 A IT 2094690A IT 1243343 B IT1243343 B IT 1243343B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
polypeptide
active substance
liquid pharmaceutical
nasal administration
Prior art date
Application number
IT02094690A
Other languages
English (en)
Other versions
IT9020946A0 (it
IT9020946A1 (it
Inventor
Giancarlo Ceschel
Antonella Maria Segu
Celestino Ronchi
Original Assignee
Phidea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phidea Spa filed Critical Phidea Spa
Priority to IT02094690A priority Critical patent/IT1243343B/it
Publication of IT9020946A0 publication Critical patent/IT9020946A0/it
Priority to ES90120880T priority patent/ES2067624T3/es
Priority to EP90120880A priority patent/EP0432431B1/en
Priority to DE9090120880T priority patent/DE69001991T2/de
Priority to AT90120880T priority patent/ATE90572T1/de
Priority to US07/716,390 priority patent/US5124315A/en
Publication of IT9020946A1 publication Critical patent/IT9020946A1/it
Application granted granted Critical
Publication of IT1243343B publication Critical patent/IT1243343B/it

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT02094690A 1989-11-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva IT1243343B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT02094690A IT1243343B (it) 1990-07-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva
ES90120880T ES2067624T3 (es) 1989-11-16 1990-10-31 Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.
EP90120880A EP0432431B1 (en) 1989-11-16 1990-10-31 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
DE9090120880T DE69001991T2 (de) 1989-11-16 1990-10-31 Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
AT90120880T ATE90572T1 (de) 1989-11-16 1990-10-31 Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
US07/716,390 US5124315A (en) 1989-11-16 1991-06-17 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02094690A IT1243343B (it) 1990-07-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva

Publications (3)

Publication Number Publication Date
IT9020946A0 IT9020946A0 (it) 1990-07-16
IT9020946A1 IT9020946A1 (it) 1992-01-16
IT1243343B true IT1243343B (it) 1994-06-10

Family

ID=11174459

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02094690A IT1243343B (it) 1989-11-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva

Country Status (1)

Country Link
IT (1) IT1243343B (it)

Also Published As

Publication number Publication date
IT9020946A0 (it) 1990-07-16
IT9020946A1 (it) 1992-01-16

Similar Documents

Publication Publication Date Title
AU2553992A (en) Bone-growth-stimulating composition
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
ATE166575T1 (de) Tramadolsalz enthaltende arzneimittel mit verzögerter wirkstofffreitsetzung
AU8199187A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
ZA896149B (en) Pharmaceutical formulation for the treatment of diabetes mellitus
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
HU9600376D0 (en) A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
DE3875108T2 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
EP0177342A3 (en) Oral formulation of therapeutic proteins
SE8804628A (it)
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE69106892D1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
IT1243343B (it) Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva
DE69120536T2 (de) Arzneimittel
AU2231688A (en) Stabilisation of therapeutically active proteins in a pharmaceutical composition
SE8204871L (sv) Farmaceutiska preparat, innefattande humant proinsulin
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them

Legal Events

Date Code Title Description
0001 Granted